{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:15:05Z","timestamp":1791807305387,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.chest.2021.10.015","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T09:17:44Z","timestamp":1634635064000},"page":"906-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management"],"prefix":"10.1016","volume":"161","author":[{"given":"Hitasha","family":"Rupani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2021.10.015_bib1","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2020. International guideline. Accessed June 2021. https:\/\/ginasthma.org\/gina-reports\/gina-2020-full-report_-final-_wms\/"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"2020 focused updates to the Asthma Management Guidelines: a report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9347","key":"10.1016\/j.chest.2021.10.015_bib3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.chest.2021.10.015_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coi.2020.10.004","article-title":"Biologic treatment options for severe asthma","volume":"66","author":"Hearn","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"5090","key":"10.1016\/j.chest.2021.10.015_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1470903","article-title":"The molecule of the year","volume":"258","author":"Koshland","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/thorax.58.2.175","article-title":"Multiple roles of nitric oxide in the airways","volume":"58","author":"Ricciardolo","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2021.10.015_bib7","first-page":"1","article-title":"Basic aspects of exhaled nitric oxide","volume":"49","author":"Alving","year":"2010","journal-title":"Eur Respir Mon"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/thorax.57.2.178","article-title":"Eosinophilic bronchitis: clinical manifestations and implications for treatment","volume":"57","author":"Gibson","year":"2002","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.chest.2021.10.015_bib10","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/1817-1737.56009","article-title":"Exhaled nitric oxide in diagnosis and management of respiratory diseases","volume":"4","author":"Abba","year":"2009","journal-title":"Ann Thorac Med"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"9842","key":"10.1016\/j.chest.2021.10.015_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.chest.2021.10.015_bib14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.chest.2021.10.015_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","article-title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","volume":"4","author":"Hanania","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2021.10.015_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","article-title":"Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials","volume":"6","author":"Panettieri","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2013.03.044","article-title":"Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects","volume":"132","author":"Hastie","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib19","doi-asserted-by":"crossref","first-page":"1800938","DOI":"10.1183\/13993003.00938-2018","article-title":"\u201cT2-high\u201d in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin","volume":"53","author":"Pavlidis","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1183\/09031936.00012415","article-title":"Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes","volume":"46","author":"Westerhof","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2021.10.015_bib22","first-page":"1","article-title":"Basic aspects of exhaled nitric oxide","volume":"49","author":"Alving","year":"2010","journal-title":"Eur Respir Mon"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191030","article-title":"Acute ingestion of beetroot juice increases exhaled nitric oxide in healthy individuals","volume":"13","author":"Kroll","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0194599812442322","article-title":"Exhaled nitric oxide measurement in patients affected by nasal polyposis","volume":"147","author":"Galli","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib25","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2500\/ajra.2012.26.3717","article-title":"Comparison of orally exhaled nitric oxide in allergic versus nonallergic rhinitis","volume":"26","author":"Kalpaklioglu","year":"2012","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1378\/chest.112.2.313","article-title":"Smoking cessation is associated with an increase in exhaled nitric oxide","volume":"112","author":"Robbins","year":"1997","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.rmed.2012.02.009","article-title":"The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms","volume":"106","author":"Malinovschi","year":"2012","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.07-1025","article-title":"Exhaled nitric oxide daily evaluation is effective in monitoring exposure to relevant allergens in asthmatic children","volume":"132","author":"Bodini","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00130832-200502000-00008","article-title":"Nitric oxide and the common cold","volume":"5","author":"Proud","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.chest.2021.10.015_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpediatrics.2010.128","article-title":"Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis","volume":"164","author":"Gadish","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1183\/09031936.96.09061130","article-title":"The effect of alcohol ingestion on exhaled nitric oxide","volume":"9","author":"Yates","year":"1996","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2021.10.015_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/02770900902779284","article-title":"Association of ambient ozone exposure with airway inflammation and allergy in adults with asthma","volume":"46","author":"Khatri","year":"2009","journal-title":"J\u00a0Asthma"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib33","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/jes.2013.25","article-title":"Airway inflammation and oxidative potential of air pollutant particles in a pediatric asthma panel","volume":"23","author":"Delfino","year":"2013","journal-title":"J\u00a0Expo Sci Environ Epidemiol"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/thorax.2003.006445","article-title":"Association between air pollution exposure and exhaled nitric oxide in an elderly population","volume":"59","author":"Adamkiewicz","year":"2004","journal-title":"Thorax"},{"issue":"suppl 61","key":"10.1016\/j.chest.2021.10.015_bib35","first-page":"PA4680","article-title":"Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma","volume":"50","author":"Hoshino","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1164\/ajrccm.160.4.9903004","article-title":"NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast","volume":"160","author":"Bisgaard","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/ajrccm.155.4.9105060","article-title":"Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group","volume":"155","author":"Tamaoki","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.10.015_bib38","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1164\/ajrccm.158.5.9707076","article-title":"Prostaglandins E2 and F2\u03b1 reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes","volume":"158","author":"Kharitonov","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1-2","key":"10.1016\/j.chest.2021.10.015_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0014-5793(98)01407-0","article-title":"Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages","volume":"440","author":"D\u2019Acquisto","year":"1998","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0024-3205(95)02311-9","article-title":"Sex differences in concentrations of exhaled nitric oxide and plasma nitrate","volume":"58","author":"Jilma","year":"1996","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-3038.2005.00255.x","article-title":"The effect of spirometry and exercise on exhaled nitric oxide in asthmatic children","volume":"16","author":"Gabriele","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.70252\/WQBR8294","article-title":"The effect of different training loads on the lung health of competitive youth swimmers","volume":"11","author":"Davies","year":"2018","journal-title":"Int J Exerc Sci"},{"issue":"12","key":"10.1016\/j.chest.2021.10.015_bib43","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1093\/cid\/ciz1223","article-title":"Fraction of exhaled nitric oxide levels are elevated in people living with HIV compared to uninfected controls suggesting increased eosinophilic airway inflammation","volume":"71","author":"Thudium","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1378\/chest.130.5.1319","article-title":"Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample","volume":"130","author":"Olin","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12890-019-0862-2","article-title":"Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic","volume":"19","author":"Azim","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib46","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1378\/chest.10-1157","article-title":"Increased nitric oxide concentrations in the small airway of older normal subjects","volume":"139","author":"Gelb","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/hrt.72.3.243","article-title":"Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle","volume":"72","author":"Kharitonov","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.chest.2021.10.015_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.niox.2018.02.005","article-title":"Studying allergic inflammation and spirometry over menstrual cycles in well-controlled asthmatic women: changes in progesterone and estradiol affect neither FENO levels nor lung function","volume":"75","author":"Nittner-Marszalska","year":"2018","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib49","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1183\/20734735.0362-2018","article-title":"Over- and under-diagnosis in asthma","volume":"15","author":"Kavanagh","year":"2019","journal-title":"Breathe (Sheff)"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/thoraxjnl-2016-208704","article-title":"Accuracy of FENO for diagnosing asthma: a systematic review","volume":"72","author":"Karrasch","year":"2017","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib51","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61688-2","article-title":"Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients","volume":"91","author":"Langley","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib52","first-page":"109","article-title":"Relationship between methacholine challenge testing and exhaled nitric oxide in adult patients with suspected bronchial asthma","volume":"46","author":"Giovannini","year":"2014","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.53.2.91","article-title":"Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma","volume":"53","author":"Jatakanon","year":"1998","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/02770903.2013.878953","article-title":"FENO and AHR mannitol in patients referred to an out-of-hospital asthma clinic: a real-life study","volume":"51","author":"Backer","year":"2014","journal-title":"J\u00a0Asthma"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaip.2015.02.005","article-title":"Combining the mannitol test and FeNO in the assessment of poorly controlled asthma","volume":"3","author":"Porsbjerg","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.chest.2021.10.015_bib56","unstructured":"BTS\/SIGN Guideline for the management of asthma. 2019. Accessed October 2020. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/guidelines\/asthma\/"},{"key":"10.1016\/j.chest.2021.10.015_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2019.07.010","article-title":"Scottish consensus statement on the role of FeNO in adult asthma","volume":"155","author":"Kuo","year":"2019","journal-title":"Respir Med"},{"issue":"82","key":"10.1016\/j.chest.2021.10.015_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19820","article-title":"Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath","volume":"19","author":"Harnan","year":"2015","journal-title":"Health Technol Assess"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib60","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2008.11.016","article-title":"Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma","volume":"123","author":"Knuffman","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2014.10.026","article-title":"Biomarker-based asthma phenotypes of corticosteroid response","volume":"135","author":"Cowan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib63","doi-asserted-by":"crossref","first-page":"1902150","DOI":"10.1183\/13993003.02150-2019","article-title":"Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib65","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/13993003.00699-2016","article-title":"Predictive value of exhaled nitric oxide in the management of asthma: a systematic review","volume":"48","author":"Lehtimaki","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-2600(17)30424-1","article-title":"Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib67","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cea.12179","article-title":"Frequent exacerbators\u2014a distinct phenotype of severe asthma","volume":"44","author":"Kupczyk","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib70","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1164\/rccm.202001-0133OC","article-title":"A\u00a0phase 2a, double-blind, placebo-controlled randomized trial of inhaled TLR9 agonist AZD1419 in asthma","volume":"203","author":"Psallidas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2021.10.015_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13601-019-0282-7","article-title":"Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations","volume":"9","author":"Price","year":"2019","journal-title":"Clin Transl Allergy"},{"issue":"7","key":"10.1016\/j.chest.2021.10.015_bib72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(20)30053-9","article-title":"Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Pavord","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"suppl 64","key":"10.1016\/j.chest.2021.10.015_bib73","first-page":"5039","article-title":"Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population","volume":"56","author":"Yang","year":"2020","journal-title":"Eur Respir J"},{"issue":"2 suppl","key":"10.1016\/j.chest.2021.10.015_bib74","doi-asserted-by":"crossref","first-page":"AB21","DOI":"10.1016\/j.jaci.2019.12.792","article-title":"Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study","volume":"145","author":"Busse","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.chest.2021.10.015_bib75","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.alit.2018.04.003","article-title":"Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma","volume":"67S","author":"Soma","year":"2018","journal-title":"Allergol Int"},{"issue":"21","key":"10.1016\/j.chest.2021.10.015_bib76","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMoa043596","article-title":"Use of exhaled nitric oxide measurements to guide treatment in chronic asthma","volume":"352","author":"Smith","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2021.10.015_bib77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial","volume":"176","author":"Shaw","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9795","key":"10.1016\/j.chest.2021.10.015_bib78","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(11)60971-9","article-title":"Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial","volume":"378","author":"Powell","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.chest.2021.10.015_bib79","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/resp.13713","article-title":"Biomarker-guided management reduces exacerbations in non-eosinophilic asthma in pregnancy: a secondary analysis of a randomized controlled trial","volume":"25","author":"Murphy","year":"2020","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib80","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.chest.2021.10.015_bib81","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","article-title":"The prevalence of nonadherence in difficult asthma","volume":"180","author":"Gamble","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib82","doi-asserted-by":"crossref","first-page":"1701836","DOI":"10.1183\/13993003.01836-2017","article-title":"Nonadherence in the era of severe asthma biologics and thermoplasty","volume":"51","author":"Lee","year":"2018","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.chest.2021.10.015_bib83","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thoraxjnl-2011-201096","article-title":"The relationship between clinical outcomes and medication adherence in difficult-to-control asthma","volume":"67","author":"Murphy","year":"2012","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib84","doi-asserted-by":"crossref","first-page":"1902259","DOI":"10.1183\/13993003.02259-2019","article-title":"Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma","volume":"55","author":"d\u2019Ancona","year":"2020","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2021.10.015_bib85","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib86","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib87","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaip.2020.10.059","article-title":"Clinical outcomes in people with difficult-to-control asthma using electronic monitoring to support medication adherence","volume":"9","author":"Boddy","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib88","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.202104-1040LE","article-title":"FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma","volume":"204","author":"Couillard","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.chest.2021.10.015_bib89","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.chest.2021.10.015_bib90","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2021.10.015_bib91","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a prospective real-world study","volume":"7","author":"Casale","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.chest.2021.10.015_bib92","doi-asserted-by":"crossref","first-page":"1800936","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.chest.2021.10.015_bib93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2021.10.015_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.chest.2020.03.042","article-title":"Real-world effectiveness and the characteristics of a \u201csuper-responder\u201d to mepolizumab in severe eosinophilic asthma","volume":"158","author":"Kavanagh","year":"2020","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib95","doi-asserted-by":"crossref","first-page":"1902420","DOI":"10.1183\/13993003.02420-2019","article-title":"Mepolizumab effectiveness and identification of super-responders in severe asthma","volume":"55","author":"Harvey","year":"2020","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2021.10.015_bib96","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201903-0599LE","article-title":"Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide, and their combination in severe asthma: a post hoc analysis","volume":"200","author":"Shrimanker","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2021.10.015_bib97","article-title":"The relationship between FeNO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma","volume":"9","author":"Hearn","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.chest.2021.10.015_bib98","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med."},{"issue":"26","key":"10.1016\/j.chest.2021.10.015_bib99","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2021.10.015_bib100","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2021.10.015_bib101","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.chest.2016.10.042","article-title":"Epithelial-derived cytokines in asthma","volume":"151","author":"Mitchell","year":"2017","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.chest.2021.10.015_bib102","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.chest.2021.10.015_bib103","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922104109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236922104109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:45:58Z","timestamp":1757925958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236922104109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S001236922104109X"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2021.10.015","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Fractional Exhaled Nitric Oxide Measurement in Clinical Asthma Management","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2021.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}